← Back to Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research

Source proof for Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research

Source-bound proof

Verified source excerpts for every supported field

Each colour maps a published value to the exact source passage used to support it. Only bounded excerpts are public; administrators can inspect the complete captured source.

12 fields supported

Title

Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research

derived · high
Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research | Microsoft Customer Stories This is the Trace Id: 64a63c9e4b6aece19639ffe874be…

Description

Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.

derived · high
…rovement, where continual progress materializes into significant steps forward. The teams recently published some of the early results with predictive AI models that center around advanced risk detection in cardiovascular diseases, the leading cause of death globally . 1 “I'm proud of what the teams are doing in cardiovascular disease. They've b…
…tnership. Accelerating scientific discovery: AI and more than 100 years of data With more than 100 years of insulin research, Novo Nordisk has an extensive amount of data and core expertise around diabetes. This has stimulated an expansion into patient care areas adjacent to diabetes,…

Company

Novo Nordisk

quote · high
…cebook , Instagram , LinkedIn , X/Twitter , and YouTube . Discover more details CUSTOMER Novo Nordisk PRODUCTS Azure Kubernetes Service Power BI Azure Power Apps Azure Cosmos DB ORG…

Country

Denmark

quote · high
…e Power BI Azure Power Apps Azure Cosmos DB ORGANIZATION SIZE 10,000+ employees COUNTRY Denmark BUSINESS NEED Scaled operations Modern infrastructure Powerful business apps Ar…

Industry

Healthcare

classification · high
…operations Modern infrastructure Powerful business apps Artificial Intelligence INDUSTRY Health Pharma Share the story Explore related stories /h2> "> Explore related stories Stories…

Problem

Developing high-quality medicine is a resource-intensive endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning.

quote · high
…e details Explore related stories Contact Sales Contact Sales Executive summary Developing high-quality medicine is a resource-intensive endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platf…

Solution

In partnership with Microsoft Research, Novo Nordisk built an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design. The platform combines unification (a single place to discover data and models), a copilot tool for researchers to reason with data and AI, shared reasoning-chain templates for collaboration, and governance auditing of how data and models are used. Microsoft Azure OpenAI Service is used alongside Azure Cosmos DB and Azure Kubernetes Service (AKS), with Power BI and Power Apps for collaboration.

derived · high
…overy, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure…
…re AI and data stacks: Unification: A single place to discover data and models. Advanced reasoning: A copilot tool for researchers to conduct reasoning with data and AI. Collaboration: A means for experts to share their reasoning chains as templates to help others. Governance: Auditing of reasoning chains and tracking of how data and models are used. Build bigger: An AI factory allowing data scientists and computational biologis…
…build new and more powerful models and share them with subject matter experts. Microsoft Azure OpenAI Service is used alongside a wide array of additional core infrastructure, such as Azure Cosmos DB for developing AI-powered apps and Azure Kubernetes Service (AKS) for deploying containers on managed Kubernetes. While scientific discoveries transpire in labs, learning and collaboration are…
…ntainers on managed Kubernetes. While scientific discoveries transpire in labs, learning and collaboration are amplified through a range of Microsoft Power Platform tools like Power BI and Power Apps . Novo Nordisk Azure OpenAI chart Microsoft Azure OpenAI Service is leveraged a…

Business value

The teams recently published early results from predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that, according to Novo Nordisk's Senior Vice President of Digital Science and Innovation, can predict patients' cardiovascular risk better than the best clinical standards.

derived · high
I’m proud of what the teams are doing in cardiovascular disease. They’ve brought forward an algorithm that can predict patients’ cardiovascular risk better than the best clinical standards out there,” says Lars Fogh Iversen, Senior Vice President of Digital Science and Innovation at Novo Nordisk.

AI capabilities

Generative AI, Machine Learning

classification · medium
…a resource-intensive endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platf…

Technology

Azure OpenAI Service, Azure Cosmos DB, Azure Kubernetes Service, Power BI, Power Apps

classification · high
…inkedIn , X/Twitter , and YouTube . Discover more details CUSTOMER Novo Nordisk PRODUCTS Azure Kubernetes Service Power BI Azure Power Apps Azure Cosmos DB ORGANIZATION SIZE 10,000+ employees COUNTRY Denmark BUSINESS NEED Scaled operat…
…ntainers on managed Kubernetes. While scientific discoveries transpire in labs, learning and collaboration are amplified through a range of Microsoft Power Platform tools like Power BI and Power Apps . Novo Nordisk Azure OpenAI chart Microsoft Azure OpenAI Service is leveraged a…

Deployment model

Cloud

classification · high
…abilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure…

Deployment options

cloud

classification · high
…abilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure…
Capture details
Captured
25 Aug 2026, 19:50 UTC
Extractor
fetch-strip@1
Snapshot hash
c9bd5d5b88b75b73fe37f545802ad059ace41b967676900a0260ce5bbb75a865